SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.72-5.2%11:48 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert K. who wrote (11126)8/11/1999 10:13:00 AM
From: aknahow  Read Replies (1) of 17367
 
Robert, since there was no mention of the patent by XOMA,I just consider it another of the many, "NON NOVEL", patents.

Suggestion for name of XOMA drug to treat OME, "Ephphatha" meaning to be opened in Hebrew, Mark 7:34

But somehow I too was impressed with the new non novel patent. Too bad all the good news is built into the price and these other potential applications won't excite anyones interest even if XOMA is able to demonstrate BPI works for meningococcemia. <G>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext